RCT
Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension
Study on active menopause symptoms and treatments.
Citation
Cosman F, Oates M, Betah D, Timoshanko J, Wang Z, Ferrari S, McClung MR. Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2024;39(9):1268-1277. doi:10.1093/jbmr/zjae116
View Source